🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Add GLP-1 receptor agonist

Found 64 matching trials

A Clinical Trial Using Tirzepatide to Help Adults With Type 1 Diabetes Automatically Control Their Blood Sugar

PHASE2

This research study is testing whether a weekly medication called tirzepati...

Status

Recruiting

Location

Institut de Recherches Cliniques de Montréal

Start Date

2026-05-19

Trial ID

NCT07284511

Treatments Being Tested

Tirzepatide Tandem Control-IQ Automated Insulin Delivery System (with Dexcom G7 CGM)Carbohydrate Counting No Meal Announcement

CARTIZ Registry: Cartilage, Arthropathy and Imaging Under Tirzepatide in Zone-stratified Cohorts - A Four-Institute Mexican Observational Registry

N/A

CARTIZ is a prospective observational clinical registry of adults in Mexico...

Status

Not Yet Recruiting

Location

IMSS Clínica Río Magdalena

Start Date

2026-05

Trial ID

NCT07567378

Treatments Being Tested

Tirzepatide

Incretin and Treatment With Inhibition of Sodium-glucose Cotransporter-2 Combination Insights Into Mechanisms Implicated in Congestive Heart Failure: "NATRIURETIC" Trial

PHASE2

This study aims to provide essential mechanistic insights into natriuretic ...

Status

Unknown

Location

Renal Physiology Laboratory

Start Date

2019-01-24

Trial ID

NCT04535960

Treatments Being Tested

Empagliflozin 25 MG + Liraglutide 1.8 MG Liraglutide 1.8 MG + Empagliflozin 25 MG

The Potential of Dapagliflozin Plus Exenatide in Obese Insulin-resistant Patients

PHASE3

This is a 28-week, multi-center, randomized, double-blind, placebo-controll...

Status

Terminated

Location

Diabeteszentrum Oldenburg

Start Date

2018-02-19

Trial ID

NCT03419624

Treatments Being Tested

Dapagliflozin 10mg Exenatide 2 mg [Bydureon]Placebo Oral Tablet Placebo injection Insulin Metformin, if taken before

POSE2.0 With GLP-1 Agonist for Obesity Management

Determine the effect on weight loss and obesity-related comorbidities in pa...

Status

Unknown

Location

Ibrahim Bin Hamad Obaidullah Hospital

Start Date

2023-01-16

Trial ID

NCT05705388

Treatments Being Tested

POSE2.0 Endoscopic Gastric Remodeling Liraglutide injection

GLP-1 and Hyperoxia for Organ Protection in Heart Surgery

Patients undergoing open heart surgery are at risk of suffering damage to t...

Status

Active Not Recruiting

Location

Rigshospitalet - Copenhagen University Hospital

Start Date

2016-02

Trial ID

NCT02673931

Treatments Being Tested

Byetta (Lilly, Exenatide)Conoxia (AGA, oxygen)20% Human Albumin

A Clinical Trial to Evaluate The Effects of Semaglutide and Empagliflozin Combined to Automated Insulin Delivery on Diabetes Control in Adults Living With Type 1 Diabetes

PHASE3

The goal of this clinical trial is to learn if Empagliflozin and Semaglutid...

Status

Recruiting

Location

Research Institute of the McGill University Health Centre

Start Date

2025-04

Trial ID

NCT06894784

Treatments Being Tested

Intervention Period 1: Semaglutide + Empagliflozin Intervention Period 2: Semaglutide + Empagliflozin Placebo Intervention Period 3: Semaglutide Placebo + Empagliflozin Intervention Period 4: Semaglutide Placebo + Empagliflozin Placebo

JOULE - Metabolic Adaptation to Weight Loss in Response to a Behavioural Lifestyle Program With or Without Semaglutide in Adolescents With Obesity

PHASE4

The Joule MARS study is a single center, randomized, open label clinical tr...

Status

Recruiting

Location

McMaster University

Start Date

2025-06-18

Trial ID

NCT06852391

Treatments Being Tested

Semaglutide Pen Injector Behavioural Lifestyle Program (BLP)

Evaluate the Detection of Retained Gastric Contents and Assess Safety Using the Flower Capsule Endoscopy in Healthy Individuals and GLP-1 Receptor Agonist Users

Clinical Study Overview Feasibility Study Plan (Study 1: Healthy Participan...

Status

Not Yet Recruiting

Location

Asian Institute of Gastroenterology Hospital

Start Date

2025-04-08

Trial ID

NCT06927401

Treatments Being Tested

Flower

Randomisation to Endobarrier Alone Versus With Incretin Analogue in SustainEd Diabesity (REVISE-Diabesity)

PHASE4

New effective non-surgical treatments are needed for patients whose obesity...

Status

Unknown

Location

Department of Diabetes, City Hospital

Start Date

2013-07

Trial ID

NCT02055014

Treatments Being Tested

Liraglutide Duodenal-jejunal bypass liner - Endobarrier device

Previous Next